Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
65
ERAS Quote, Financials, Valuation and Earnings
Last price:
$3.49
Seasonality move
:
-10.52%
Day range:
$3.36 - $3.50
52-week range:
$1.01 - $3.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.84x
Volume:
1M
Avg. volume:
2.3M
1-year change:
32.82%
Market cap:
$987.3M
Revenue:
--
EPS (TTM):
-$0.45
Analysts' Opinion
-
Consensus RatingErasca, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.13, Erasca, Inc. has an estimated upside of 47.27% from its current price of $3.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $3.48.
Fair Value
-
According to the consensus of 7 analysts, Erasca, Inc. has 47.27% upside to fair value with a price target of $5.13 per share.
ERAS vs. S&P 500
-
Over the past 5 trading days, Erasca, Inc. has underperformed the S&P 500 by -4.67% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Erasca, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Erasca, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Erasca, Inc. reported revenues of --.
Earnings Growth
-
Erasca, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Erasca, Inc. reported earnings per share of -$0.11.
Enterprise value:
747.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-7.59x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.2M
Return On Assets:
-26.96%
Net Income Margin (TTM):
--
Return On Equity:
-32.03%
Return On Invested Capital:
-28.42%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$3.7M | -$3.9M | -$3.2M | -$842K | -$755K | |
| Operating Income | -$245.7M | -$155.2M | -$134.5M | -$37.2M | -$32.5M | |
| EBITDA | -$242M | -$151.4M | -$131.3M | -$36.4M | -$31.8M | |
| Diluted EPS | -$1.70 | -$0.83 | -$0.45 | -$0.11 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $492.3M | $365.8M | $306M | $330.2M | $299.9M | |
| Total Assets | $521.9M | $446.4M | $419.4M | $528.9M | $420.4M | |
| Current Liabilities | $19.6M | $27.7M | $26.7M | $30M | $28.7M | |
| Total Liabilities | $39M | $81.1M | $80.4M | $78.9M | $72.5M | |
| Total Equity | $483M | $365.3M | $339M | $450M | $347.9M | |
| Total Debt | $20.2M | $53.4M | $52.9M | $48.5M | $43.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$102.8M | -$109.6M | -$98.3M | -$22.4M | -$21.7M | |
| Cash From Investing | -$100.6M | -$174.7M | $98.3M | -$102.6M | $25.7M | |
| Cash From Financing | $97M | $240.4M | $1.3M | $21.1M | $41K | |
| Free Cash Flow | -$105.4M | -$109.8M | -$98.4M | -$22.4M | -$21.7M | |
ERAS
Sector
Market Cap
$987.3M
$28.2M
Price % of 52-Week High
91.58%
51.2%
Dividend Yield
0%
0%
Shareholder Yield
-0.03%
-1.54%
1-Year Price Total Return
32.82%
-18.1%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.52
200-day SMA
Buy
Level
$1.86
Bollinger Bands (100)
Buy
Level
1.65 - 3.01
Chaikin Money Flow
Sell
Level
-7.6M
20-day SMA
Buy
Level
$3.36
Relative Strength Index (RSI14)
Buy
Level
58.12
ADX Line
Buy
Level
36.37
Williams %R
Neutral
Level
-49.2308
50-day SMA
Buy
Level
$2.86
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
20.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.92)
Sell
CA Score
(Annual)
Level (-0.5072)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.4849)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, ERAS has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ERAS average analyst price target in the past 3 months is $5.13.
-
Where Will Erasca, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Erasca, Inc. share price will rise to $5.13 per share over the next 12 months.
-
What Do Analysts Say About Erasca, Inc.?
Analysts are divided on their view about Erasca, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Erasca, Inc. is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is Erasca, Inc.'s Price Target?
The price target for Erasca, Inc. over the next 1-year time period is forecast to be $5.13 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ERAS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Erasca, Inc. is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ERAS?
You can purchase shares of Erasca, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Erasca, Inc. shares.
-
What Is The Erasca, Inc. Share Price Today?
Erasca, Inc. was last trading at $3.49 per share. This represents the most recent stock quote for Erasca, Inc.. Yesterday, Erasca, Inc. closed at $3.48 per share.
-
How To Buy Erasca, Inc. Stock Online?
In order to purchase Erasca, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ERAS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ERAS
Sector
P/E ratio
--
23.92x
PEG ratio
--
-0.01x
P/B ratio
2.84x
1.83x
Price / LTM sales
--
1.61x
Growth Metrics
ERAS
Sector
Revenue growth
--
4.6%
Earnings growth
2.35%
10.88%
Revenue (5-year growth)
--
6.46%
Earnings forecast
-$0.11
-$0.21
Profitability
ERAS
Sector
Profitability FY 2024
-$3.8M
$3.5M
Return on invested capital
-28.42%
-31.84%
Return on assets
-26.96%
-27.96%
Return on equity
-32.03%
-37.63%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
11
Balance Sheet
ERAS
Sector
Total cash
$288.4M
$26.3M
Short term investments
$230.6M
$25.7M
Total assets
$502.5M
$76.9M
Long term debt
$43.4M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
